AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Pierfrancesco Tassone

Pierfrancesco Tassone

Universita degli Studi Magna Graecia di Catanzaro - Catanzaro / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1854154
University Magna Graecia of Catanzaro
person_outline Pierfrancesco Tassone's MOST POPULAR ARTICLES
1-) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial The lancet oncology 18 (12), 1688-1700, 2017
2-) Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 … The Lancet Oncology 17 (3), 367-377, 2016
3-) Mir-34: a new weapon against cancer? Molecular therapy Nucleic acids 3, 2014
4-) Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma Blood, The Journal of the American Society of Hematology 114 (2), 371-379, 2009
5-) BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells British journal of cancer 88 (8), 1285-1291, 2003